The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Honoraria - AstraZeneca; Eisai; Lilly; Merck; Pfizer; Roche; Seagen
Overall survival (OS) update of the double-blind placebo (PBO)-controlled randomized phase 2 LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for locally advanced/metastatic triple-negative breast cancer (mTNBC).
 
Rebecca Dent
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Hanmi; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst)
 
Marc Espie
Travel, Accommodations, Expenses - Novartis
 
Sibel Blau
Employment - University of Washington (I)
Leadership - Northwest Medical Specialties
Stock and Other Ownership Interests - Northwest Medical Specialties
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Northwest Medical Specialties
Expert Testimony - Northwest Medical Specialties
Travel, Accommodations, Expenses - Northwest Medical Specialties
Other Relationship - All4Cure (I); Northwest Medical Specialties; Quality Cancer Care Alliance
 
Antoinette R. Tan
Honoraria - Agendia
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie (Inst); Advaxis (Inst); Bayer/Onyx (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Caris Life Sciences
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Genentech/Roche; PharmaMar
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Genentech (Inst); Merck (Inst); OncoPep (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Mafalda Oliveira
Consulting or Advisory Role - Roche/Genentech
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)
 
Cristina Saura
Consulting or Advisory Role - Pfizer; Puma Biotechnology; Roche
Research Funding - AstraZeneca (Inst); Genentech (Inst)
 
Matthew Wongchenko
Employment - Genentech/Roche
Stock and Other Ownership Interests - ARIAD; Genentech/Roche
 
Amy V. Kapp
Employment - Genentech/Roche; Genentech/Roche (I)
Stock and Other Ownership Interests - Roche; Roche (I)
 
Wai Y. Chan
Employment - BeiGene; Genentech
Stock and Other Ownership Interests - Genentech
 
Stina M. Singel
No Relationships to Disclose
 
Daniel J. Maslyar
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - GRAIL; Lilly; Novartis
 
Sung-Bae Kim
Research Funding - Dongkook (Inst); Novartis (Inst); Samyang (Inst); Sanofi (Inst)